GO
Loading...

Enter multiple symbols separated by commas

Search results for "lilly"

REFINE RESULTS

ANY FORMAT

Blog Posts
News
Slideshows
Special Reports
» Video
Wires

Press Releases

SEARCH RESULTS

About 17 results. Sort By: Date | Relevance
Cholesterol drug wars  

After Regeneron and Sanofi got FDA approval for their cholesterol drug last month, today is Amgen's turn. CNBC's Meg Tirrell reports.
Source: CNBC.com
4 Stocks, 4 trades: VRX, LLY, GPRO & LB  

The FMHR traders take their positions on four stocks making news today, including Valeant buying Sprout Pharmaceuticals.
Source: CNBC.com
Cramer's Mad Dash: Eli Lilly gets a lift  

Jim Cramer explains why he is watching shares of Eli Lilly and Lumber Liquidators.
Source: CNBC.com
Box's enterprise strategy  

Box CEO Aaron Levie, discusses growing financial services accounts, and earnings growth.
Source: CNBC.com
Zulily & Liberty good fit: Wayfair CEO  

Niraj Shah, Wayfair CEO, joins Closing Bell to discuss consolidation in the commerce company space, retail buyouts, and his business strategy.
Source: CNBC.com
Liberty buys Zulily for $2.4 billion  

Mike George, President & CEO, QVC, explains why the company decided to spend $2.4 billion to buy online retailer Zulily.
Source: CNBC.com
IPO fallout stocks  

CNBC's Dominic Chu reports on IPO meltdowns, including Zulilly getting taken out by Liberty Interactive.
Source: CNBC.com
Zulily natural fit for QVC: Liberty Interactive CEO  

Greg Maffei, Liberty Interactive president & CEO discusses his company's $2.4 billion acquisition on Zulily.
Source: CNBC.com
Market opens down triple digits  

CNBC's Courtney Reagan reports on what's moving in early morning trading, including a look at whether oil will break below $40.
Source: CNBC.com
Are biotechs too expensive?  

Jason Kolbert, Maxim Group senior biotechnology analyst, and CNBC's Meg Tirrell discuss the biotech sector and biotech valuations.
Source: CNBC.com